Eptifibatide no ka mālama ʻana i ka maʻi maʻi maʻi maʻi 188627-80-7

ʻO Etifibatide (integrilin) ​​​​he mea hou polypeptide platelet glycoprotein IIb/IIIa receptor antagonist, ka mea e pale ai i ka platelet aggregation a me ka thrombosis ma ke kāohi ʻana i ke ala maʻamau hope o ka platelet aggregation. Hoʻohālikelike ʻia me ka monoclonal antibody abciximab, ʻoi aku ka ikaika o ka eptifibatide, ʻoi aku ka kuhikuhi a me ka paʻa kikoʻī iā GPIIb/IIIa ma muli o ka loaʻa ʻana o hoʻokahi conservative amino acid substitution-lysine e pani i ka arginine. No laila, pono e loaʻa ka hopena therapeutic maikaʻi i ka mālama interventional o ka maʻi coronary acute. Platelet glycoprotein IIb/IIIa receptor antagonist lāʻau i hoʻomohala nui ʻia, a i kēia manawa aia he 3 mau ʻano hoʻomākaukau i hiki ke hoʻohana ʻia i ka lāʻau lapaʻau honua, abciximab, eptifibatide a me tirofiban. ). ʻAʻohe ʻike liʻiliʻi i ka hoʻohana ʻana i ka platelet glycoprotein GPIIb/IIIa receptor antagonists ma Kina, a ʻo nā lāʻau lapaʻau i loaʻa hoʻi i kaupalena ʻia. Hoʻokahi wale nō lāʻau, ʻo tirofiban hydrochloride, aia ma ka mākeke. No laila, ua kūkulu ʻia kahi platelet glycoprotein IIb hou. /IIIa receptor antagonists imperative. ʻO ka eptifibatide home kahi huahana hoʻohālike i hana ʻia e Chengdu Sino Biological Products Co., Ltd.